The differential detection of methicillin-resistant, methicillin-susceptible and borderline oxacillin-resistant Staphylococcus aureus by surface plasmon resonance

Biosensors and Bioelectronics

Volumn 49, Issue , 2013, Pages 334-340

  Tawil, Nancy ^a,b   Mouawad, Flaviana ^b   Lévesque, Simon ^c   Sacher, Edward ^a   Mandeville, Rosemonde ^b   Meunier, Michel ^a  

^a ÉCOLE POLYTECHNIQUE DE MONTRÉAL   (Canada)

^b Biophage Pharma Inc   (Canada)

^c INSTITUT NATIONAL DE SANTÉ PUBLIQUE DU QUÉBEC   (Canada)

Author keywords

Biosensor; Borderline oxacillin resistant Staphylococcus aureus (BORSA); Methicillin resistant Staphylococcus aureus (MRSA); Methicillin sensitive Staphylococcus aureus (MSSA); Penicillin binding protein (PBP); Surface plasmon resonance (SPR)

Indexed keywords

COLONY FORMING UNITS; DIFFERENTIAL DETECTION; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; METHICILLIN-SENSITIVE STAPHYLOCOCCUS AUREUS; PENICILLIN-BINDING PROTEINS; SPECIFIC DETECTION; STAPHYLOCOCCUS AUREUS; SURFACE PLASMON RESONANCE BIOSENSOR;

BACTERIA; BIOSENSORS; PLASMONS; PROTEINS;

SURFACE PLASMON RESONANCE;

AMPICILLIN; BETA LACTAM ANTIBIOTIC; CEFAZOLIN; CEFTRIAXONE; CIPROFLOXACIN; GENOMIC DNA; METICILLIN; OXACILLIN; PENICILLIN BINDING PROTEIN 2A;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM DETECTION; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; BINDING AFFINITY; BIOSENSOR; BORDERLINE OXACILLIN RESISTANT STAPHYLOCOCCUS AUREUS; COLONY FORMING UNIT; CONTROLLED STUDY; DNA SEQUENCE; LIGHT EMITTING DIODE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; METHICILLIN SUSCEPTIBLE STAPHYLOCOCCUS AUREUS; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; POLYMERASE CHAIN REACTION; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; STAPHYLOCOCCUS AUREUS; STRAIN DIFFERENCE; SURFACE PLASMON RESONANCE;

BIOSENSOR; BORDERLINE OXACILLIN-RESISTANT STAPHYLOCOCCUS AUREUS (BORSA); METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS (MRSA); METHICILLIN-SENSITIVE STAPHYLOCOCCUS AUREUS (MSSA); PENICILLIN-BINDING PROTEIN (PBP); SURFACE PLASMON RESONANCE (SPR);

ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; DRUG RESISTANCE, BACTERIAL; HUMANS; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; OXACILLIN; PENICILLIN-BINDING PROTEINS; SENSITIVITY AND SPECIFICITY; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; SURFACE PLASMON RESONANCE;

METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS AUREUS;

EID: 84879541946     PISSN: 09565663     EISSN: 18734235     Source Type: Journal    
DOI: 10.1016/j.bios.2013.05.031     Document Type: Article

References (42)

1. Adam H.J., DeCorby M., Rennie R., Karlowsky J.A., Hoban D.J., Zhanel G.G., et al. Diagnostic Microbiology and Infectious Disease 2011, 69:307-313.
2. Altschul S.F., Gish W., Miller W., Myers E.W., Lipman D.J. Journal of Molecular Biology 1990, 215:403-410.
3. Bekkaoui F., McNevin J.P., Leung C.H., Peterson G.J., Patel A., Bhatt R.S., et al. Diagnostic Microbiology and Infectious Disease 1999, 34:83-90.
4. Berger-Bachi B., Rohrer S. Archives of Microbiology 2002, 178:165-171.
5. Biedenbach D.J., Moet G.J., Jones R.N. Diagnostic Microbiology and Infectious Disease 2004, 50:59-69.
6. Burke J.P. New England Journal of Medicine 2003, 348:651-656.
7. CLSI. Performance standards for antimicrobial susceptibility testing; twenty-third informational supplement. M100-S23 Pennsylvania: Wayne; 2013.
8. Cavassini M., Wenger A., Jaton K., Blanc D.S., Bille J. Journal of Clinical Microbiology 1999, 37:1591-1594.
9. Chambers H.F. Clinical Microbiology Reviews 1997, 10:781-&.
10. Chen YWWH, Hupert M., Soper S.A. Analyst 2013, 138:1075-1083.
11. Corrigan D.K., Schulze H., Henihan G., Ciani I., Giraud G., Terry J.G., et al. Biosensors and Bioelectronics 2012, 34:178-184.
12. Dallaire A.M., Rioux D., Rachkov A., Patskovsky S., Meunier M. Journal of Physical Chemistry C 2012, 116:11370-11377.
13. Garcia-Alvarez L., Holden M.T.G., Lindsay H., Webb C.R., Brown D.F.J., Curran M.D., et al. Lancet Infectious Diseases 2011, 11:595-603.
14. Golding GCJL, Spreitzer D.J., Veyhl J., Surynicz K., Simor A., Mulvey M.R. Canadian Journal of Infectious Diseases and Medical Microbiology 2008, 19:273-281.
15. Hackbarth C.J., Chambers H.F. Antimicrobial agents and Chemotherapy 1989, 33:995-999.
16. Harmsen D., Claus H., Witte W., Rothganger J., Claus H., Turnwald D., et al. Journal of Clinical Microbiology 2003, 41:5442-5448.
17. Hiramatsu K., Kihara H., Yokota T. Microbiology and Immunology 1992, 36:445-453.
18. Hoban D.J., Biedenbach D.J., Mutnick A.H., Jones R.N. Diagnostic Microbiology and Infectious Disease 2003, 45:279-285.
19. Jorgensen J.H. Infection Control and Hospital Epidemiology 1991, 12:14-19.
20. Kelley P.G., Grabsch E.A., Howden B.P., Gao W., Grayson M.L. Journal of Clinical Microbiology 2009, 47:3769-3772.
21. Knapp C.C., Ludwig M.D., Washington J.A. Journal of Clinical Microbiology 1994, 32:2588-2589.
22. Krishna S., Miller L.S. Seminars in Immunopathology 2012, 34:261-280.
23. Leahy T.R., Yau Y.C.W., Atenafu E., Corey M., Ratjen F., Waters V. Pediatric Pulmonology 2011, 46:489-496.
24. Lévesque S. Surveillance des souches de Staphylococcus aureus résistantes à la méthicilline isolées des bactériémies dans la province de Québec, rapport 2011-2012. INSPQ.
25. Lina G., Piemont Y., Godail-Gamot F., Bes M., Peter M.O., Gauduchon V., et al. Clinical Infectious Diseases 1999, 29:1128-1132.
26. Lindsey W.C., Woodruff E.S., Weed D., Ward D.C., Jenison R.D. Diagnostic Microbiology and Infectious Disease 2008, 61:273-279.
27. Liu H., Buescher G., Lewis N., Snyder S., Jungkind D. European Journal of Clinical Microbiology and Infectious Diseases 1990, 9:717-724.
28. Louie L., Matsumura S.O., Choi E., Louie M., Simor A.E. Journal of Clinical Microbiology 2000, 38:2170-2173.
29. Lukashin A.V., Borodovsky M. Nucleic Acids Research 1998, 26:1107-1115.
30. Milheirico C., Oliveira D.C., de Lencastre H. Antimicrobial Agents and Chemotherapy 2007, 51:3374-3377.
31. Panlilio A.L., Culver D.H., Gaynes R.P., Banerjee S., Henderson T.S., Tolson J.S., et al. Infection Control and Hospital Epidemiology 1992, 13:582-586.
32. Pantosti A., Venditti M. European Respiratory Journal 2009, 34:1190-1196.
33. Parker D., Prince A. Seminars in Immunopathology 2012, 34:281-297.
34. Pearson W.R. Methods in Enzymology 1990, 183:63-98.
35. Ramirez P., Fernandez-Barat L., Torres A. Current Opinion in Infectious Diseases 2012, 25:159-165.
36. Rognes T., Seeberg E. Bioinformatics 2000, 16:699-706.
37. Shiga KGK, Nishimura M., Watanabe M., Nomura F., Kajiyama N. Journal of Immunological Methods 2013, 388.
38. Simor A.E., Gilbert N.L., Gravel D., Mulvey M.R., Bryce E., Loeb M., et al. Infection control and Hospital Epidemiology 2010, 31:348-356.
39. Stefani S., Chung D.R., Lindsay J.A., Friedrich A.W., Kearns A.M., Westh H., et al. International Journal of Antimicrobial Agents 2012, 39:273-282.
40. Tawil N., Sacher E., Mandeville R., Meunier M. Biosensors and Bioelectronics 2012, 37:24-29.
41. Tong S.Y.C., Chen L.F., Fowler V.G. Seminars in Immunopathology 2012, 34:185-200.
42. Wertheim H.F.L., Melles D.C., Vos M.C., van Leeuwen W., van Belkum A., Verbrugh H.A., et al. Lancet Infectious Diseases 2005, 5:751-762.